EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Potential mechanisms and targeting strategies of the gut microbiota in antitumor immunity and immunotherapy

Qian Yin iD, Jiao-Jiao Ni, Jie-Er Ying

Immunity, Inflammation and Disease · 2024

DOI: 10.1002/iid3.1263 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Qian Yin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Immunotherapy, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Anti-Cancer Association-Qilu Clinical Research, Zhejiang Provincial Natural Science Foundation of China, Special Research Support for Post-marketing Clinical Research of Innovative Drugs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immunotherapies, notably immune checkpoints inhibitors that target programmed death 1/programmed death ligand 1(PD‐1/PD‐L1) and cytotoxic T lymphocyte‐associated antigen 4 (CTLA‐4), had profoundly changed the way advanced and metastatic cancers are treated and dramatically improved overall and progression‐free survival.

Aims

This review article aimed to explore the underlying molecular mechanisms by which the gut microbiota affects antitumor immunity and the efficacy of cancer immunotherapy.

Methods

We summarized the latest knowledge supporting the associations among the gut microbiota, antitumor immunity, and immunotherapy. Moreover, we disscussed the therapeutic strategy for improving immunotherapy efficacy by modulating gut microbiota in cancer treatment.

Results

The potential molecular mechanisms underlying these associations are explained in terms of four aspects: immunomodulation, molecular mimicry, mamps, and microbial metabolites.

Conclusion

The gut microbiota significantly impacts antitumor immunity and alters the effectiveness of cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeImmunotherapyNeoplasmsHumansAnimalsImmune Checkpoint InhibitorsImmunomodulation

Stichwörter der Autor:innen

antitumor immunitycancercancer therapygut microbiotaimmunotherapy

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, China.
  • Department of Hepato-Pancreato-Biliary & Gastric Medical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.

ORCID-Profile: Qian Yin

Förderung

  • Zhejiang Anti-Cancer Association-Qilu Clinical Research
  • Zhejiang Provincial Natural Science Foundation of China
  • Special Research Support for Post-marketing Clinical Research of Innovative Drugs
  • China Postdoctoral Science Foundation

Zitieren

APA

Yin, Q., Ni, J. J., & Ying, J. E. (2024). Potential mechanisms and targeting strategies of the gut microbiota in antitumor immunity and immunotherapy. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1263

Vancouver

Yin Q, Ni JJ, Ying JE. Potential mechanisms and targeting strategies of the gut microbiota in antitumor immunity and immunotherapy. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.1263

BibTeX
@article{Yin2024,
  author = {Yin, Qian and Ni, Jiao-Jiao and Ying, Jie-Er},
  title = {Potential mechanisms and targeting strategies of the gut microbiota in antitumor immunity and immunotherapy},
  journal = {Immunity, Inflammation and Disease},
  year = {2024},
  doi = {10.1002/iid3.1263}
}
Kostenlos starten →